V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014082 | 220008569 | 1.76 | 85 | Curative (C) | 2014-03-04 | 2014-04-11 | AML Int Guide ADE 8+3+5 (2) | N | N | 220032351 | ADE |
| 220014083 | 220008571 | 1.68 | 124.4 | Not known (9) | 2015-03-21 | 2015-03-23 | BOSUTINIB | 02 | Y | 220032353 | BOSUTINIB |
| 220014084 | 220008571 | 1.7 | null | Curative (C) | 2014-07-28 | 2014-07-28 | Triple Intrathecal | 02 | N | 220032353 | TRIPLE INTRATHECAL |
| 220014085 | 220008572 | null | 21.45 | Curative (C) | null | 2016-09-05 | Methotrexate intrathecal | Y | N | 220032358 | METHOTREXATE INTRATHECAL |
| 220014087 | 220008574 | null | 74 | Curative (C) | 2013-07-21 | 2013-07-21 | BOSUTINIB | N | N | 220032371 | BOSUTINIB |
| 220014088 | 220008576 | 1.55 | 70.9 | Adjuvant (A) | 2012-09-27 | 2014-05-07 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220032372 | IDARUBICIN + TRETINOIN |
| 220014089 | 220008577 | 1.58 | 59.3 | Curative (C) | 2013-10-13 | 2013-10-16 | AML Int Guide ADE 8+3+5 (2) | N | N | 220032378 | ADE |
| 220014090 | 220008580 | 1.83 | 88 | Curative (C) | 2015-11-05 | 2015-12-25 | BOSUTINIB | Y | N | 220032380 | BOSUTINIB |
| 220014091 | 220008581 | 1.6 | 68 | null | null | 2017-02-19 | RUXOLITINIB | N | N | 220032382 | RUXOLITINIB |
| 220014092 | 220014634 | 1.9 | 71.8 | Palliative (P) | 2013-05-19 | 2013-05-29 | RUXOLITINIB | N | N | 220032382 | RUXOLITINIB |
| 220014093 | 220008583 | 1.77 | 8.8 | Adjuvant (A) | 2015-03-28 | 2015-04-02 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032386 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014094 | 220008584 | 1.55 | 55 | Disease modification (D) | 2013-09-17 | 2013-09-17 | Cyclophosphamide TBI Allograft | N | N | 220032392 | CYCLOPHOSPHAMIDE |
| 220014095 | 220014635 | 1.85 | 106.8 | Curative (C) | 2017-06-29 | 2017-06-29 | BOSUTINIB | N | N | 220032392 | BOSUTINIB |
| 220014096 | 220008585 | 1.64 | null | Palliative (P) | 2014-07-29 | 2014-07-29 | Methotrexate intrathecal | N | N | 220032405 | METHOTREXATE INTRATHECAL |
| 220014097 | 220008587 | 1.85 | 119 | null | 2017-09-15 | 2017-09-22 | IDARUBICIN + TRETINOIN | N | N | 220032407 | IDARUBICIN + TRETINOIN |
| 220014098 | 220008587 | 1.66 | 14.8 | Adjuvant (A) | 2014-12-10 | 2015-01-26 | RUXOLITINIB | N | null | 220032407 | RUXOLITINIB |
| 220014099 | 220008588 | 1.76 | 71.8 | Curative (C) | 2014-01-15 | 2014-01-19 | Triple Intrathecal | N | Y | 220032418 | TRIPLE INTRATHECAL |
| 220014100 | 220008591 | 0 | 57.3 | Disease modification (D) | null | 2016-12-24 | RUXOLITINIB | 02 | N | 220032418 | RUXOLITINIB |
| 220014101 | 220008593 | 1.53 | null | Curative (C) | 2017-08-04 | 2017-08-06 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032423 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014102 | 220008594 | 1.6 | 75 | Palliative (P) | 2016-11-17 | 2016-12-28 | Methotrexate intrathecal | Y | N | 220032429 | METHOTREXATE INTRATHECAL |
| 220014103 | 220014641 | 1.55 | 56.7 | Curative (C) | 2013-08-18 | 2013-08-31 | Methotrexate intrathecal | N | N | 220032429 | METHOTREXATE INTRATHECAL |
| 220014104 | 220008595 | 1.8 | 109 | Disease modification (D) | 2015-11-18 | 2015-11-28 | BOSUTINIB | 02 | N | 220032447 | BOSUTINIB |
| 220014105 | 220008596 | 1.7 | null | Curative (C) | 2013-05-13 | 2013-05-26 | Triple Intrathecal | N | N | 220032460 | TRIPLE INTRATHECAL |
| 220014106 | 220008597 | 0 | 77.1 | Palliative (P) | 2016-07-09 | 2016-07-09 | AML Int Guide ADE 8+3+5 (2) | 2 | N | 220032464 | ADE |
| 220014110 | 220008604 | 1.62 | 57.7 | Curative (C) | 2013-07-12 | 2013-07-21 | Triple Intrathecal | N | N | 220032476 | TRIPLE INTRATHECAL |
| 220014111 | 220008607 | 1.54 | 0 | Palliative (P) | 2015-08-09 | 2015-09-06 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220032495 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014112 | 220008608 | 1.83 | 90.8 | Palliative (P) | 2015-07-03 | 2015-07-10 | BOSUTINIB | 2 | N | 220032496 | BOSUTINIB |
| 220014113 | 220008609 | 1.77 | 73.7 | Adjuvant (A) | 2015-12-24 | 2015-12-24 | AML16 DA 3+8 | N | N | 220032501 | AML16 TRIAL |
| 220014114 | 220008609 | 1.83 | 61.5 | Disease modification (D) | 2012-10-11 | 2012-10-17 | AML16 DA 3+8 | N | N | 220032501 | AML16 TRIAL |
| 220014115 | 220008609 | 1.68 | 75 | Curative (C) | 2013-12-17 | 2015-03-14 | RUXOLITINIB | 02 | N | 220032501 | RUXOLITINIB |
| 220014116 | 220008609 | null | 74.9 | Palliative (P) | 2018-01-12 | 2018-01-13 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220032501 | IDARUBICIN + TRETINOIN |
| 220014118 | 220008611 | 1.63 | 56 | Not known (9) | 2013-10-05 | 2013-10-05 | BOSUTINIB | N | null | 220032519 | BOSUTINIB |
| 220014119 | 220008612 | 0 | 92.6 | Curative (C) | 2015-09-13 | 2015-09-15 | RUXOLITINIB | N | N | 220032520 | RUXOLITINIB |
| 220014120 | 220008612 | 1.6 | null | Not known (9) | 2015-08-01 | 2015-08-02 | AML16 DA 3+10 | N | N | 220032520 | AML16 TRIAL |
| 220014121 | 220008613 | null | 58.5 | null | 2015-10-31 | 2015-11-03 | AML Int Guide ADE 10+3+5 (1) | N | N | 220032522 | ADE |
| 220014122 | 220008614 | 1.59 | 58.5 | Curative (C) | 2015-06-18 | 2015-06-19 | FLAG | Y | N | 220032524 | FLAG |
| 220014123 | 220008617 | 1.73 | 112 | Curative (C) | null | 2015-06-30 | FLAG | Y | N | 220032527 | FLAG |
| 220014124 | 220008618 | 1.7 | 83.2 | Curative (C) | 2018-01-20 | 2018-01-20 | CYCLOPHOSPHAMIDE + FLUDARABINE | Y | N | 220032527 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014125 | 220008619 | 1.64 | 73 | Disease modification (D) | 2015-10-02 | 2015-11-22 | BOSUTINIB | N | N | 220032532 | BOSUTINIB |
| 220014126 | 220008626 | 1.71 | 68.8 | Curative (C) | 2013-07-09 | 2013-08-26 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032533 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014127 | 220008626 | 1.81 | 60 | Palliative (P) | 2014-12-22 | 2014-12-22 | IDARUBICIN + TRETINOIN | N | N | 220032533 | IDARUBICIN + TRETINOIN |
| 220014128 | 220008626 | 0 | null | Curative (C) | 2015-07-30 | 2015-07-30 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220032533 | IDARUBICIN + TRETINOIN |
| 220014129 | 220008627 | 1.75 | null | Curative (C) | 2013-05-19 | 2014-06-14 | FLAG | N | N | 220032555 | FLAG |
| 220014130 | 220008627 | 1.83 | 79 | Disease modification (D) | 2014-11-03 | 2014-11-19 | Methotrexate intrathecal | N | N | 220032555 | METHOTREXATE INTRATHECAL |
| 220014131 | 220008629 | 1.78 | 102.9 | Curative (C) | 2017-06-06 | 2017-06-14 | BOSUTINIB | null | Y | 220032572 | BOSUTINIB |
| 220014132 | 220008630 | 0.99 | null | Disease modification (D) | 2015-01-21 | 2015-02-02 | FLAG | N | N | 220032574 | FLAG |
| 220014133 | 220008630 | null | 80 | Curative (C) | 2015-02-10 | 2015-03-21 | FLAG | Y | N | 220032574 | FLAG |
| 220014134 | 220008631 | null | 98.75 | Disease modification (D) | null | 2014-11-26 | Triple / Double Intrathecal Therapy | null | null | 220032589 | TRIPLE INTRATHECAL |
| 220014135 | 220008632 | 1.78 | 68 | null | 2014-01-18 | 2014-01-19 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220032602 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014136 | 220008636 | 1.55 | 21.5 | Curative (C) | 2016-01-30 | 2016-02-04 | Cyclophosphamide TBI Allograft | 02 | null | 220032603 | CYCLOPHOSPHAMIDE |